Impact of Academic Detailing on Proton Pump Inhibitor Prescribing Behaviour in a Community Hospital

Batuwitage BT Kingham J Morgan NE Morgan R . Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007;83:66–8.

Mat Saad AZ Collins N Lobo MM O'Connor HJ . Proton pump inhibitors: a survey of prescribing in an Irish general hospital. Int J Clin Pract 2005;59:31–4.

Scagliarini R Magnani E Pratico A . Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice. Dig Dis Sci 2005;50:2307–11.

Cunningham R Dale B Undy B Gaunt N . Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243–5.

Laheij R Sturkenboom M Hassing R . Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955–60.

Neal KR Scott HM Slack RCB Logan RFA . Omeprazole as risk factor for Campylobacter gastroenteritis: case-control study. Br Med J 1996;312:414–15.

Grindrod KA Patel P Martin JE . What interventions should pharmacists employ to impact health practitioners' prescribing practices? Ann Pharmacother 2006;40:1546–57.

O'Brien MA Rogers S Jamtvedt G . Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007;4:CD000409.

Ofman JJ Segal R Russell WL . A randomized trial of an acid-peptic disease management program in a managed care environment. Am J Manag Care 2003;9:425–33.

Khoshbaten M Fattahi E Naderi N . A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer. BMC Gastroenterol 2006;6:2.

Bytzer P Aalykke C Rune S . Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol 2000;35(10): 1023–32.

Sung JJ Chung SC Ling TK . Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332(3):139–42.

Salas M Ward A Caro J . Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials. BMC Gastroenterol 2002;2:17.

Higuchi K Fujiwara Y Tominaga K . Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther 2003;17(1):111–7.

Tunis SR Sheinhait IA Schmid CH . Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis. Clin Ther 1997;19(4):743–57.

Axon AT O'Moráin CA Bardhan KD . Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997;314(7080)565–8.

Khoshbaten M Fattahi E Naderi N . A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer. BMC Gastroenterol 2006;6:2.

Hasseigren G Lind T Lundell L . Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997;32(4):328–33.

Lau JY Sung JJ Lee KK . Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343(5):310–6.

Kaviani MJ Hashemi MR Kazemifar AR . Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003;17(2):211–6.

Wei KL Tung SY Sheen CH . Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. J Gastroenterol Hepatol 2007;22(1):43–6.

Hsu PI Lo GH Lo CC . Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol 2004;10(24):3666–9.

Zargar SA Javid G Khan BA . Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. J Gastroenterol Hepatol 2006;21(4):716–21.

Hung WK Li VK Chung CK . Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers. ANZ J Surg 2007;77(8):677–81.

Udd M Miettinen P Palmu A . Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scand J Gastroenterol 2001;36(12):1332–8.

Kim JI Cheung DY Cho SH . Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial. Dig Dis Sci 2007;52(12):3371–6.

Bustamante M Stollman N . The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review. J Clin Gastroenterol 2000;30(1):7–13.

Lai KC Lam SK Chu KM . Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users — a randomized trial. Aliment Pharmacol Ther 2003;18(8):829–36.

Giral A Ozdogan O Celikel CA . Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury. J Gastroenterol Hepatol 2004;19(7):773–7.

Lai KC Lam SK Chu KM . Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002;346(26):2033–8.

van Zanten SJOV Chiba N Armstrong D . A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN study. Am J Gastroenterol 2005;100(7): 1477–88.

Katz PO Castell DO Chen Y . Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study. Aliment Pharmacol Ther 2004;20(4):399–406.

Morocutti A Merrouche M Bjaaland T . An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. Aliment Pharmacol Ther 2006;24(10):1439–44.

Metz DC Comer GM Soffer E . Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. Aliment Pharmacol Ther 2006;23(3):437–44.

Cook DJ Fuller HD Guyatt GH . Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330:377–81.

Levy MJ Seelig CB Robinson NJ . Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997;42:1255–9.

Phillips JO Metzler MH Huckfeldt RE . A multicenter, prospective, randomized clinical trial of continuous infusion IV ranitidine vs. omeprazole suspension in the prophylaxis of stress ulcers. Crit Care Med 1998;26:101A.

Kantorova I Svoboda P Scheer P . Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 2004;51:757–61.

Conrad SA Gabrielli A Margolis B . Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous Cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005;33:760–5.

van Pinxteren B Numans ME Bonis PA Lau J . Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2006;3:CD002095.

Canadian Agency for Drugs and Technologies in Health. Optimal Therapy Report. Evidence for PPI use in gastroesophageal reflux disease, dyspepsia and peptic ulcer disease: scientific report. COMPUS 2007;1(2). Available: www.cadth.ca/media/pdf/compus_Scientific_Report_final.pdfg (accessed Nov. 1, 2010).

Khan M Santana J Donnellan C . Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev 2007;2:CD003244.

Delaney B Ford AC Forman D . Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2005;4:CD001961.

Moayyedi P Shelly S Deeks JJ . Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;4:CD001960.

Figura N Minoli G Fedeli G . Omeprazole versus ranitidine in the prevention of duodenal ulcer recurrence after eradication therapy. Curr Ther Res 1995;56(6):568–72.

Marzio L Cellini L Angelucci D . Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial. Dig Liver Dis 2003;35(1):20–3.

Leontiadis GI Sharma VK Howden CW . Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006;1:CD002094.

Yeh RW Gerson LB Triadafilopoulos G . Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus. Dis Esophagus 2003;16:193–8.

Peters FT Ganesh S Kuipers EJ . Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut 1999;45(4):489–94.

Bugden S MacNair K . Proton pump inhibitor therapy. April 2007 Available: www.cadth.ca/index.php/en/compus/ppis (accessed Feb. 4, 2011).

Meineche-Schmidt V . Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption. Am J Gastroenterol 2004;99(6): 1050–8.

Steward DL Wilson KM Kelly DH . Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004;131(4):342–50.

Chang AB Lasserson TJ Gaffney J . Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 2006;4:CD004823.

Gibson PG Henry RL Coughlan JL . Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003;1:CD001496.

Khan M Santana J Donnellan C . Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev 2007;2:CD003244.

Dickman R Emmons S Cui H . The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2005;22:547–55.

Vila P Espachs P Echevarria V . Acid aspiration prophylaxis in elective biliary surgery: a comparison of omeprazole and famotidine using manually aided gastric aspiration. Anaesthesia 1994;49:909–11.

Levack ID Bowie RA Braid DP . Comparison of the effect of two dose schedules of oral omeprazole with oral ranitidine on gastric aspirate pH and volume in patients undergoing elective surgery. Br J Anaesth 1996;76:567–9.

Memis D Turan A Karamanlioglu B . The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery. Anesth Analg 2003;97:1360–3.

Skala I Mareckova O Vitko S . Prophylaxis of acute gastroduodenal bleeding after renal transplantation. Transpl Int 1997;10:375–8.

Gon S Irie Y Takahashi M . Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings. Jpn J Thorac Cardiovasc Surg 2006;54:278–84.

Liberman JD Whelan CT . Brief report: reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention. J Gen Intern Med 2006;21:498–500.

Van den Hombergh P Grol R van den Hoogen HJM van den Bosch WJHM . Practice visits as a tool in quality improvement: mutual visits and feedback by peers compared with visits and feedback by non-physician observers. Qual Health Care 1999;8:161–6.